Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Jan 25, 2025. (Total: 235671Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 7 (of 7 Records)

Query Trace: Breast Neoplasms and MLL3[original query]
Somatic mutations of the mixed-lineage leukemia 3 (MLL3) gene in primary breast cancers.
Pathology oncology research : POR 2011 Jun 17 (2): 429-33.
Wang Xin-Xin, Fu Liya, Li Xuan, Wu Xiao, Zhu Zhengmao, Fu Li, Dong Jin-Ta
Analysis of functional germline variants in APOBEC3 and driver genes on breast cancer risk in Moroccan study population.
BMC cancer 2016 16 (1): 165.
Marouf Chaymaa, Göhler Stella, Filho Miguel Inacio Da Silva, Hajji Omar, Hemminki Kari, Nadifi Sellama, Försti As
Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians.
Breast cancer research and treatment 2017 Feb 161 (3): 491-499.
Ademuyiwa Foluso O, Tao Yu, Luo Jingqin, Weilbaecher Katherine, Ma Cynthia
Molecular features in young vs elderly breast cancer patients and the impacts on survival disparities by age at diagnosis.
Cancer medicine 2018 5 7 (7): 3269-3277.
Wang Mei-Xia, Ren Jun-Ting, Tang Lu-Ying, Ren Ze-Fa
Multimodal liquid biopsy for early monitoring and outcome prediction of chemotherapy in metastatic breast cancer.
NPJ breast cancer 2021 9 7 (1): 115.
Bortolini Silveira Amanda, Bidard François-Clément, Tanguy Marie-Laure, Girard Elodie, Trédan Olivier, Dubot Coraline, Jacot William, Goncalves Anthony, Debled Marc, Levy Christelle, Ferrero Jean-Marc, Jouannaud Christelle, Rios Maria, Mouret-Reynier Marie-Ange, Dalenc Florence, Hego Caroline, Rampanou Aurore, Albaud Benoit, Baulande Sylvain, Berger Frédérique, Lemonnier Jérôme, Renault Shufang, Desmoulins Isabelle, Proudhon Charlotte, Pierga Jean-Yv
DNA damage response as a prognostic indicator in metastatic breast cancer via mutational analysis.
Annals of translational medicine 2021 Feb 9 (3): 220.
Rong Guohua, Yi Zongbi, Ma Fei, Guan Yanfang, Xu Yaping, Li Lifeng, Xu Bing
Predictive biomarkers of response and survival following immunotherapy with a PD-L1 inhibitor benmelstobart (TQB2450) and antiangiogenic therapy with a VEGFR inhibitor anlotinib for pretreated advanced triple negative breast cancer.
Signal transduction and targeted therapy 2023 11 8 (1): 429.
Yiqun Han, Jiayu Wang, Tao Sun, Quchang Ouyang, Jianwen Li, Jie Yuan, Binghe
TOP